GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
0.417
-0.052 (-11.14%)
At close: Mar 9, 2026, 4:00 PM EDT
0.437
+0.020 (4.80%)
After-hours: Mar 9, 2026, 7:17 PM EDT
GT Biopharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 13 | 8 | 7 | 11 | 29 | 93 | |
| Market Cap Growth | 174.12% | 22.55% | -35.48% | -63.37% | -69.01% | 159.67% | |
| Enterprise Value | 6 | 6 | 0 | -5 | 8 | 57 | |
| Last Close Price | 0.42 | 0.79 | 3.05 | 7.65 | 26.57 | 91.50 | |
| PB Ratio | 1.84 | 1.44 | -4.08 | 1.41 | 2.46 | 4.25 | |
| P/TBV Ratio | 2.27 | 1.44 | - | 1.41 | 2.46 | 4.25 | |
| Debt / Equity Ratio | - | - | - | 0.01 | 0.02 | 0.00 | |
| Net Debt / Equity Ratio | -1.18 | -1.18 | 2.37 | -1.86 | -1.39 | -1.46 | |
| Net Debt / FCF Ratio | 0.53 | 0.53 | 0.31 | 1.57 | 1.07 | 2.05 | |
| Quick Ratio | 2.94 | 2.94 | 0.67 | 2.11 | 3.34 | 3.12 | |
| Current Ratio | 3.50 | 3.50 | 0.72 | 2.12 | 3.35 | 3.14 | |
| Return on Equity (ROE) | -1377.41% | -1377.41% | -453.39% | -79.09% | -124.15% | - | |
| Return on Assets (ROA) | -125.85% | -125.85% | -97.89% | -55.02% | -54.33% | -190.04% | |
| Return on Capital Employed (ROCE) | -214.70% | -214.70% | 860.10% | -181.60% | -180.20% | -262.50% | |
| Earnings Yield | -261.81% | -339.51% | -193.14% | -71.93% | -72.42% | -62.35% | |
| FCF Yield | -98.15% | -154.63% | -189.36% | -83.81% | -52.77% | -16.77% | |
| Buyback Yield / Dilution | -190.57% | -190.57% | -40.78% | -26.87% | -13.18% | -542.06% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.